Your reference journal for coronary, valvular and structural interventions

Articles

10.4244/EIJV8I10A182 • Feb 22, 2013

Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial

Egede R, Jensen L, Hansen H, Hansen K, Junker A, Thayssen P

free

10.4244/EIJV8I10A183 • Feb 22, 2013

Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design

Kelly D, McCann G, Blackman D, Curzen N, Dalby M, Greenwood J, Fairbrother K, Shipley L, Kelion A, Heatherington S, Khan JM, Nazir S, Alahmar A, Flather M, Swanton H, Schofield P, Gunning M, Hall R, Gershlick A

free

10.4244/EIJV8I10A184 • Feb 22, 2013

Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients

Velders M, Boden H, van der Hoeven B, Liem S-S, Atary J, van der Wall E, Jukema J, Schalij M

free

10.4244/EIJV8I10A185 • Feb 22, 2013

Immediate vs. delayed stenting in acute myocardial infarction: a systematic review and meta-analysis

Freixa X, Belle L, Joseph L, Tanguay J, Souteyrand G, L’Allier P, Jolicœur E

free

10.4244/EIJV8I10A186 • Feb 22, 2013

How should I treat a patient with symptomatic severe aortic stenosis and a 23 mm aortic annulus who is referred for transcatheter aortic valve replacement using the CoreValve prosthesis?

Ko B, Antonis P, Meredith I, Tchétché D, Eggebrecht H, Zierer A, Doss M

free

10.4244/EIJV8I10A187 • Feb 22, 2013

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

Garcia-Garcia H, Schultz C, Duckers H, Regar E, Ligthart J, Serruys PW, van Geuns R

free

10.4244/EIJV8I9A151 • Jan 18, 2013

The authors’ challenge

Serruys PW

free

10.4244/EIJV8I9A152 • Jan 18, 2013

Catheter-based renal denervation: a word of caution

Mahfoud F, Kjeldsen S

free

10.4244/EIJV8I9A153 • Jan 18, 2013

First-in-man, last in evidence?

Brugaletta S, Sabaté M

free

10.4244/EIJV8I9A154 • Jan 18, 2013

Innovation in education: what’s new in 2013?

Fajadet J

free

10.4244/EIJV8I9A155 • Jan 18, 2013

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study

Hamon M, Niculescu R, Deleanu D, Dorobantu M, Weissman N, Waksman R

free

10.4244/EIJV8I9A156 • Jan 18, 2013

First-in-man evaluation of the MOMO cobalt-chromium carbon-coated stent

Kesavan S, Strange J, Johnson T, Flohr-Roese S, Baumbach A

free

10.4244/EIJV8I9A157 • Jan 18, 2013

First-in-man assessment of a dedicated guidewire for transcatheter aortic valve implantation

Roy D, Laborde J-C, Sharma R, Jahangiri M, Brecker S

free

10.4244/EIJV8I9A158 • Jan 18, 2013

First clinical experience with the GARDEX EPD: a novel embolic protection device for carotid artery stenting

Werner M, Scheinert D, Borghesi R, Cremonesi A, Rosenchein U, Scheinert S, Braunlich S, Bausback Y, Ulrich M, Schmidt A

free

10.4244/EIJV8I9A159 • Jan 18, 2013

Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial

Dangas G, Claessen B, Mehran R, Xu K, Stone GW

free

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Readers

Current issue